Skip to search.
 FTSE 100 Up 1.16%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
543.73 Down 8.72(1.58%) 16:59 - Nasdaq Real Time Price
Add to Portfolio
Prev Close:552.45
Open:555.23
Bid:544.13 x 100
Ask:545.06 x 100
1y Target Est:530.13
Beta:1.03
Next Earnings Date: 4-Aug-15REGN Earnings announcement
Day's Range:541.59 - 558.29
52wk Range:310.69 - 569.91
Volume:273,865
Avg Vol (3m):730,690
Market Cap:57.23b
P/E (ttm):174.44
EPS (ttm):3.12
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNDown 1.58%57.23b
AMGNDown 0.39%130.82b
NVSUp 0.93%250.57b
RHHBYUp 0.82%247.68b

Key Statistics

Forward P/E (1 yr):39.87
P/S (ttm):18.44
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :11.15
Quarterly EPS Est (Jun-15) :2.77
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):2.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback